Adding Help to an HLA-A*24:02 Tumor-Reactive Γδtcr Increases Tumor Control.
Frontiers in Immunology(2021)
Key words
cancer immunotherapy,TEGs,mouse model,preclinical (in vivo) studies,TCR engineering,human leukocyte antigens (HLA),persistence,efficacy
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined